Redhill BiopharmaRDHL
那斯達克 · USD
1.20
-0.11
(-8.40%)
收盤 08/02 03:38 (UTC+8)
盤後
1.20
1.20
(0.00%)
08/02 03:38 (UTC+8)
Redhill BiopharmaRDHL
1.20
-0.11
(-8.40%)
財務數據
損益表
- 0.22
- 0.22
- 0.18
- 0.18
- 0.18
- 0.13
- 0.04
- 0.02
- -
- -
- 0.50
- 2.14
- -17.38
- 0.60
- -4.33
- -27.09
- -71.88
- -50.10
- -
- -
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2024/Q4 | 2024/Q2 | 2023/Q2 | 2023/Q1 | 2022/Q4 | 2022/Q3 | 2022/Q2 | 2022/Q1 | 2021/Q4 | 2021/Q3 | |
營業收入淨額 | - | - | 1,796 | 3,599 | 12,798 | 17,552 | 18,346 | 18,236 | 22,071 | 21,609 |
營業成本 | - | - | 806 | 1,612 | 8,598 | 9,451 | 8,995 | 8,034 | 19,334 | 9,229 |
營業毛利 | - | - | 990 | 1,987 | 4,200 | 8,101 | 9,351 | 10,202 | 2,737 | 12,380 |
營業費用 | - | - | 5,398 | -27,093 | 14,148 | 15,209 | 18,510 | 23,440 | 23,436 | 29,778 |
研發費用 | - | - | 1,247 | 1,084 | 1,133 | 1,612 | 1,472 | 3,062 | 5,868 | 5,818 |
推銷及管理費用 | - | - | 8,060 | 10,907 | 13,015 | 13,597 | 17,038 | 20,378 | 17,568 | 23,960 |
非經常性項目費用 | - | - | - | - | - | - | - | - | - | - |
其他營業費用 | - | - | -3,909 | -39,084 | - | - | - | - | - | - |
營業利益 | - | - | -4,408 | 29,080 | -9,948 | -7,108 | -9,159 | -13,238 | -20,699 | -17,398 |
其他收入及費用 | - | - | - | - | - | - | - | - | - | - |
利息費用 | - | - | 1,926 | 421 | 1,427 | 31,783 | 4,214 | 3,909 | 3,593 | 4,006 |
稅前純益 | - | - | 761 | 50,241 | -3,729 | -35,701 | -11,711 | -17,137 | -24,373 | -21,387 |
所得稅 | - | - | - | - | - | - | - | - | - | - |
稅後純益 | - | - | 761 | 50,241 | -3,729 | -35,701 | -11,711 | -17,137 | -24,373 | -21,387 |
基本每股稅後盈餘(元) | - | - | 0.26 | 20.00 | 0.00 | -0.60 | -0.20 | -0.40 | - | -0.50 |
稀釋每股稅後盈餘(元) | - | - | 0.26 | 20.00 | 0.00 | -0.60 | -0.20 | -0.40 | - | -0.50 |
基本平均股數(千股) | - | - | 3877.00 | 2512.00 | 1861470.00 | 63836.00 | 56830.00 | 51320.00 | - | 46790.00 |
稀釋平均股數(千股) | - | - | 3877.00 | 2512.00 | 1861470.00 | 63836.00 | 56830.00 | 51320.00 | - | 46790.00 |
還原基本每股稅後盈餘(元) | - | - | 6.45 | 500.00 | 0.00 | -600.00 | -200.00 | -400.00 | - | -500.00 |
還原稀釋每股稅後盈餘(元) | - | - | 6.45 | 500.00 | 0.00 | -600.00 | -200.00 | -400.00 | - | -500.00 |
還原基本平均股數(千股) | - | - | 155 | 100 | 1,861 | 63 | 56 | 51 | - | 46 |
還原稀釋平均股數(千股) | - | - | 155 | 100 | 1,861 | 63 | 56 | 51 | - | 46 |
EBITDA(千元) | 0 | 0 | -56,213 | 111,147 | -294 | -1,826 | -5,581 | -11,090 | -9,587 | -15,040 |